- This event has passed.
Brain & Spine Tumor Board
March 25, 2020 @ 12:00 pm - 1:00 pm
The Brain and Spine Tumor Board is provided by Rutgers New Jersey Medical School, Department of Neurosurgery & Rutgers Cancer Institute of New Jersey at University Hospital. On Wednesday, March 25th, the Brain and Spine Tumor Board will be meeting via WebEx. Please send an email to aa2077@njms.rutgers.edu to obtain the WebEx link.
Presenters:
Dr. Anupama Chundury, MD, Assistant Professor of Radiation Oncology and Dr. Leroy R. Sharer, MD, Professor of Pathology (Neuropathology)
Objectives
At the conclusion of this activity, participants should be better able to:
- Discuss the pathophysiology and management of patients with brain and spine tumors to improve specialty-specific neuro-oncological care
- Correlate the clinical presentation of cases with the pathological, radiological, and surgical findings
- Discuss treatment options for specific presented oncological cases, particularly the most challenging ones from the institution
- Apply best practices in cancer care as established by multiple organizations in oncology
Target Audience
This activity is designed for neurosurgeons, radiation oncologists, medical oncologists, neuro-radiologists, neuro-pathologists), nurses, and clinical research staff.
In support of improving patient care, Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
Physicians: Rutgers Biomedical and Health Sciences designate this live activity for a maximum of 1AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: This activity is awarded 1 contact hour. (60 minute CH)
Disclosure Declarations
Dr. Anupama Chundury and Dr. Leroy R. Sharer and have no relevant financial relationships to disclose.
Speakers are required to disclose discussion of off-label/investigational uses of commercial products/devices in their presentation. These disclosures will be made to the audience at the time of the activity.
Planning Committee:
Pankaj K. Agarwalla, MD, Ricci Cahili, APN, and Rukaiyah Ferguson, APN have no relevant financial relationships to disclose.